Get started
Author

Joana Gorica

Observed name: Gorica J
ORCID: 0000-0001-6868-4494
Observed ORCID: 0000-0001-6868-4494
OpenAlex ID: A5049968775
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review
2023 · Marko Magdi Abdou Sidrak, Maria Silvia De Feo, et al. · International Journal of Molecular Sciences · 48
PDF
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature
2023 · Priscilla Guglielmo, Pierpaolo Alongi, et al. · Life · 44
PDF
PET Imaging of Neuro-Inflammation with Tracers Targeting the Translocator Protein (TSPO), a Systematic Review: From Bench to Bedside
2023 · Ferdinando Corica, Maria Silvia De Feo, et al. · Diagnostics · 32
PDF
FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature
2024 · Priscilla Guglielmo, Pierpaolo Alongi, et al. · Cancers · 26
PDF
Role of Exendin-4 Functional Imaging in Diagnosis of Insulinoma: A Systematic Review
2023 · Marko Magdi Abdou Sidrak, Maria Silvia De Feo, et al. · Life · 19
PDF
Gastrin-releasing peptide receptor agonists and antagonists for molecular imaging of breast and prostate cancer: from pre-clinical studies to translational perspectives
2022 · Joana Gorica, Maria Silvia De Feo, et al. · Expert Review of Molecular Diagnostics · 18
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score
2023 · Francesco Dondi, Achille Lazzarato, et al. · Life · 14
PDF
Novel Theranostic Approaches Targeting CCR4-Receptor, Current Status and Translational Prospectives: A Systematic Review
2023 · Joana Gorica, Maria Silvia De Feo, et al. · Pharmaceuticals · 13
PDF
Emerging Role of [18F]FLT PET/CT in Lymphoid Malignancies: A Review of Clinical Results
2024 · Anna Giulia Nappi, Giulia Santo, et al. · Hematology Reports · 12
PDF
Radiolabeled Dendrimer Coated Nanoparticles for Radionuclide Imaging and Therapy: A Systematic Review
2023 · Miriam Conte, Maria Silvia De Feo, et al. · Pharmaceutics · 10
PDF
Imaging of Tauopathies with PET Ligands: State of the Art and Future Outlook
2023 · Miriam Conte, Maria Silvia De Feo, et al. · Diagnostics · 8
PDF
Clinicians’ perspectives on PET/CT in oncological patients: an Italian National Survey
2023 · Giulia Santo, Alberto Miceli, et al. · Clinical and Translational Imaging · 5
PDF
Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand?
2024 · Francesco Dondi, Alberto Miceli, et al. · Bioengineering · 4
Primary Mediastinal B-Cell Lymphoma and [18F]FDG PET/CT: What We Learned and What Is New
2025 · Anna Giulia Nappi, Francesco Dondi, et al. · Hematology Reports · 3
PDF
Medication and ECG Patterns That May Hinder SPECT Myocardial Perfusion Scans
2023 · Marko Magdi Abdou Sidrak, Maria Silvia De Feo, et al. · Pharmaceuticals · 2
PDF
Radiotheranostic Agents Targeting Neuroblastoma: State-of-the-Art and Emerging Perspectives
2021 · Luca Filippi, Viviana Frantellizzi, et al. · Onco · 2
PDF
A Systematic Review on Dementia and Translocator Protein (TSPO): When Nuclear Medicine Highlights an Underlying Expression
2023 · Miriam Conte, Maria Silvia De Feo, et al. · Biomolecules · 1
PDF
Addressing unmet needs in nuclear medicine: Italian experience with PET/CT features and structured reporting in oncology
2026 · Alberto Miceli, Giulia Santo, et al. · La radiologia medica
Works count: 19
Citation count: 261
H-index: 10
I10-index: 10
Year
Topic
Type